In silico modulation of Diabetes melitus through bioactive compounds
BIOCHEMICAL AND CELLULAR ARCHIVES · 27.02.2026 · 26 (1) · 675-681
DOI: 10.51470/bca.2026.26.1.675 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIOCHEMICAL AND CELLULAR ARCHIVES, online erschienen am 05.03.2026. Verfasst von Balakrishnaraja Rengaraju und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
A major global health concern, age-related diabetes, mostly type 2 diabetes mellitus (T2DM), is typified by decreased glucose metabolism and insulin resistance. The translocation of glucose transporter 4 (GLUT4) to the plasma membrane in response to insulin signalling is a crucial mechanism in glucose management; T2DM impairs this process. The ability of natural bioactive chemicals to alter biological pathways with fewer adverse effects than synthesised medications has drawn attention to them. In order to determine which bioactive substances have the highest binding affinity to improve glucose uptake, this study investigates the interaction between GLUT4 and 20 bioactive substances with documented anti-diabetic and antioxidant qualities. PyRx and AutoDock Vina were used for molecular docking and the target protein was GLUT4. Among the compounds examined are curcumin, quercetin, berberine, resveratrol and metformin (used as a control). The evaluation of binding affinities was done using free energy (kcal/mol). Among the tested compounds, cinnamon polyphenols demonstrated the strongest binding affinity (-9.3 kcal/mol), indicating a robust potential to enhance GLUT4 activity. Other promising agents included resveratrol, genistein, and sulforaphane. These results suggest that natural compounds, especially cinnamon polyphenols, may offer effective alternatives for improving glucose uptake in insulin-resistant cells. These results demonstrate the potential of natural substances in the treatment of age-related diabetes. To confirm their effectiveness and clarify molecular pathways, more in vitro and in vivo research is needed.
Zitieren
APA
Rengaraju, B., Ramanan, B., Asmi, G., & Aniskumar, M. (2026). In silico modulation of Diabetes melitus through bioactive compounds. BIOCHEMICAL AND CELLULAR ARCHIVES, 26(1), 675-681. https://doi.org/10.51470/bca.2026.26.1.675
Vancouver
Rengaraju B, Ramanan B, Asmi G, Aniskumar M. In silico modulation of Diabetes melitus through bioactive compounds. BIOCHEMICAL AND CELLULAR ARCHIVES. 2026;26(1):675-681. doi:10.51470/bca.2026.26.1.675
BibTeX
@article{Rengaraju2026,
author = {Rengaraju, Balakrishnaraja and Ramanan, B. and Asmi, Gnana and Aniskumar, M.},
title = {In silico modulation of Diabetes melitus through bioactive compounds},
journal = {BIOCHEMICAL AND CELLULAR ARCHIVES},
year = {2026},
volume = {26},
number = {1},
pages = {675--681},
doi = {10.51470/bca.2026.26.1.675}
}
EUVIMED